Literature DB >> 17699568

Viral sequence evolution in acute hepatitis C virus infection.

Thomas Kuntzen1, Joerg Timm, Andrew Berical, Lia L Lewis-Ximenez, Andrea Jones, Brian Nolan, Julian Schulze zur Wiesch, Bin Li, Arne Schneidewind, Arthur Y Kim, Raymond T Chung, Georg M Lauer, Todd M Allen.   

Abstract

CD8(+)-T-cell responses play an important role in the containment and clearance of hepatitis C virus (HCV) infection, and an association between viral persistence and development of viral escape mutations has been postulated. While escape from CD8+ -T-cell responses has been identified as a major driving force for the evolution of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV), a broader characterization of this relationship is needed in HCV infection. To determine the extent, kinetics, and driving forces of HCV sequence evolution, we sequenced the entire HCV genome longitudinally in four subjects monitored for up to 30 months after acute infection. For two subjects the transmission sources were also available. Of 53 total non-envelope amino acid substitutions detected, a majority represented forward mutations away from the consensus sequence. In contrast to studies in HIV and SIV, however, only 11% of these were associated with detectable CD8+ T-cell responses. Interestingly, 19% of non-envelope mutations represented changes toward the consensus sequence, suggesting reversion in the absence of immune pressure upon transmission. Notably, the rate of evolution of forward and reverse mutations correlated with the conservation of each residue, which is indicative of structural constraints influencing the kinetics of viral evolution. Finally, the rate of sequence evolution was observed to decline over the course of infection, possibly reflective of diminishing selection pressure by dysfunctional CD8+ T cells. Taken together, these data provide insight into the extent to which HCV is capable of evading early CD8+ T-cell responses and support the hypothesis that dysfunction of CD8+ T cells may be associated with failure to resolve HCV infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699568      PMCID: PMC2168804          DOI: 10.1128/JVI.00995-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.

Authors:  Caroline S Fernandez; Ivan Stratov; Robert De Rose; Katrina Walsh; C Jane Dale; Miranda Z Smith; Michael B Agy; Shiu-Lok Hu; Kendall Krebs; David I Watkins; David H O'connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

Authors:  Andrea L Cox; Timothy Mosbruger; Georg M Lauer; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

3.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

Authors:  J T Gerlach; H M Diepolder; M C Jung; N H Gruener; W W Schraut; R Zachoval; R Hoffmann; C A Schirren; T Santantonio; G R Pape
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation.

Authors:  David H O'Connor; Adrian B McDermott; Kendall C Krebs; Elizabeth J Dodds; Jacqueline E Miller; Edna J Gonzalez; Timothy J Jacoby; Levi Yant; Helen Piontkivska; Ralph Pantophlet; Dennis R Burton; William M Rehrauer; Nancy Wilson; Austin L Hughes; David I Watkins
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.

Authors:  Todd M Allen; Marcus Altfeld; Shaun C Geer; Elizabeth T Kalife; Corey Moore; Kristin M O'sullivan; Ivna Desouza; Margaret E Feeney; Robert L Eldridge; Erica L Maier; Daniel E Kaufmann; Matthew P Lahaie; Laura Reyor; Giancarlo Tanzi; Mary N Johnston; Christian Brander; Rika Draenert; Jurgen K Rockstroh; Heiko Jessen; Eric S Rosenberg; Simon A Mallal; Bruce D Walker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Humoral immune response in acute hepatitis C virus infection.

Authors:  Dale M Netski; Tim Mosbruger; Erik Depla; Geert Maertens; Stuart C Ray; Robert G Hamilton; Stacy Roundtree; David L Thomas; Jane McKeating; Andrea Cox
Journal:  Clin Infect Dis       Date:  2005-07-22       Impact factor: 9.079

7.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.

Authors:  Stuart C Ray; Liam Fanning; Xiao-Hong Wang; Dale M Netski; Elizabeth Kenny-Walsh; David L Thomas
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

8.  CD8 epitope escape and reversion in acute HCV infection.

Authors:  Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

9.  Immune evasion versus recovery after acute hepatitis C virus infection from a shared source.

Authors:  Ian Tester; Susan Smyk-Pearson; Ping Wang; Anne Wertheimer; Ermei Yao; David M Lewinsohn; John E Tavis; Hugo R Rosen
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

10.  Cellular immune selection with hepatitis C virus persistence in humans.

Authors:  Andrea L Cox; Timothy Mosbruger; Qing Mao; Zhi Liu; Xiao-Hong Wang; Hung-Chih Yang; John Sidney; Alessandro Sette; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

View more
  61 in total

Review 1.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

2.  Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Authors:  Arthur Y Kim; Thomas Kuntzen; Joerg Timm; Brian E Nolan; Melanie A Baca; Laura L Reyor; Andrew C Berical; Andrea J Feller; Kristin L Johnson; Julian Schulze zur Wiesch; Gregory K Robbins; Raymond T Chung; Bruce D Walker; Mary Carrington; Todd M Allen; Georg M Lauer
Journal:  Gastroenterology       Date:  2010-09-24       Impact factor: 22.682

Review 3.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

4.  The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Authors:  Eui-Cheol Shin; Su-Hyung Park; Michelina Nascimbeni; Marian Major; Laura Caggiari; Valli de Re; Stephen M Feinstone; Charles M Rice; Barbara Rehermann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection.

Authors:  Cassandra B Jabara; Fengyu Hu; Katie R Mollan; Sara E Williford; Prema Menezes; Yan Yang; Joseph J Eron; Michael W Fried; Michael G Hudgens; Corbin D Jones; Ronald Swanstrom; Stanley M Lemon
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

6.  Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.

Authors:  Victoria Kasprowicz; Yu-Hoi Kang; Michaela Lucas; Julian Schulze zur Wiesch; Thomas Kuntzen; Vicki Fleming; Brian E Nolan; Steven Longworth; Andrew Berical; Bertram Bengsch; Robert Thimme; Lia Lewis-Ximenez; Todd M Allen; Arthur Y Kim; Paul Klenerman; Georg M Lauer
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Rare birds in North America: acute hepatitis C cohorts.

Authors:  Andrea L Cox; Kimberly Page; Julie Bruneau; Naglaa H Shoukry; Georg M Lauer; Arthur Y Kim; Hugo R Rosen; Hank Radziewicz; Arash Grakoui; Daniel S Fierer; Andrea D Branch; David E Kaplan; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2008-12-04       Impact factor: 22.682

8.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

9.  Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs.

Authors:  Perry Evans; William Dampier; Lyle Ungar; Aydin Tozeren
Journal:  BMC Med Genomics       Date:  2009-05-18       Impact factor: 3.063

10.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.